Newsletter
Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

JAMA Editor’s Summary

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue
July 1, 2014

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp